Research map: Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy

Back to the article

Papers in this map

  1. Hallmarks of Cancer: New Dimensions · Douglas Hanahan · 2022 · 9836 citations · Cited by this paper
  2. Patient rights in precision oncology: right treatment, right time, right dose, right order, right place · Elena Fountzilas · 2025 · 6 citations · Related
  3. Ferroptosis: mechanisms, biology and role in disease · Xuejun Jiang · 2021 · 7672 citations · Cited by this paper
  4. Epilepsy: Epidemiology, Molecular Pathogenesis, and Clinical Management · 2026 · Related
  5. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma · Richard S. Finn · 2020 · 7562 citations · Cited by this paper
  6. Preoperative Albumin Infusion Reduced Pulmonary Complications in Elderly Patients With Hypoalbuminemia Undergoing Cardiac Surgery: A Single‐Center, Randomized, Double‐Blind, Controlled Pilot Trial · 2026 · Related
  7. Myeloid-derived suppressor cells as regulators of the immune system · Dmitry I. Gabrilovich · 2009 · 6808 citations · Cited by this paper
  8. CD8 + Tissue‐Resident Memory T Cells in Health and Disease · 2026 · Related
  9. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells · Sanjeev Mariathasan · 2018 · 5733 citations · Cited by this paper
  10. MYC in Oncogenesis and Therapeutic Implications · 2026 · Related
  11. Immunogenic cell death and DAMPs in cancer therapy · Dmitri V. Krysko · 2012 · 3239 citations · Cited by this paper
  12. Current state of CAR-T cell therapies for solid tumors · 2026 · Related
  13. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid · Oscar R. Colegio · 2014 · 3068 citations · Cited by this paper
  14. The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives · 2025 · Related
  15. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications · Yuanyuan Zhang · 2020 · 2897 citations · Cited by this paper
  16. Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma · 2026 · Related
  17. VEGF in Signaling and Disease: Beyond Discovery and Development · Rajendra S. Apte · 2019 · 2796 citations · Cited by this paper
  18. Differential assembly of mouse and human tumor microenvironments · 2026 · Related
  19. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma · Robert H.I. Andtbacka · 2015 · 2670 citations · Cited by this paper
  20. Next-generation programmable cell therapies for precision medicine · 2026 · Related
  21. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges · Dai Fukumura · 2018 · 2048 citations · Cited by this paper
  22. Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma · Hussein A. Tawbi · 2022 · 1891 citations · Cited by this paper
  23. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis · Daniele V. F. Tauriello · 2018 · 1890 citations · Cited by this paper
  24. Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 · Omar Qureshi · 2011 · 1862 citations · Cited by this paper
  25. Tumor microenvironment complexity and therapeutic implications at a glance · Roghayyeh Baghban · 2020 · 1825 citations · Cited by this paper
  26. Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma · Robert John Motzer · 2021 · 1811 citations · Cited by this paper
  27. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients · Diwakar Davar · 2021 · 1752 citations · Cited by this paper
  28. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts · David Roulois · 2015 · 1579 citations · Cited by this paper
  29. Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy · Weiyi Peng · 2015 · 1573 citations · Cited by this paper
  30. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial · Derin B. Keskin · 2018 · 1481 citations · Cited by this paper
  31. Immune-related adverse events of checkpoint inhibitors · Manuel Ramos‐Casals · 2020 · 1441 citations · Cited by this paper
  32. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer · Luis Alfonso Rojas · 2023 · 1407 citations · Cited by this paper
  33. The cancer metabolic reprogramming and immune response · Longzheng Xia · 2021 · 1369 citations · Cited by this paper
  34. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting · Hirokazu Matsushita · 2012 · 1309 citations · Cited by this paper
  35. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy · Dongjun Peng · 2015 · 1223 citations · Cited by this paper
  36. Detection of immunogenic cell death and its relevance for cancer therapy · Jitka Palich Fucikova · 2020 · 1166 citations · Cited by this paper
  37. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation · Karthik Dhatchinamoorthy · 2021 · 1107 citations · Cited by this paper
  38. High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types · Daniel James McGrail · 2021 · 1094 citations · Cited by this paper
  39. The technological landscape and applications of single-cell multi-omics · Alev Baysoy · 2023 · 1041 citations · Cited by this paper

Source: OpenAlex (CC0)